Indivior to appeal court verdict over Suboxone Film patents


Indivior, which specialises in addiction treatment drugs, intends to launch an appeal against a US District Court for the District of Delaware verdict that could lead to rival companies selling a generic version of its Suboxone Film, a drug to treat opioid addiction. 

Indivior, US District Court for the District of Delaware, US Food and Drug Administration, Abbreviated New Drug Applications, Shaun Thaxter, patent